Mass-forming neoplastic extramedullary hematopoiesis mimics myeloid sarcoma in a patient with chronic phase chronic myeloid leukemia

Int J Lab Hematol. 2021 Jun;43(3):e135-e137. doi: 10.1111/ijlh.13432. Epub 2020 Dec 13.
No abstract available

Keywords: BCR-ABL1; chronic myeloid leukemia; chronic phase; myeloid sarcoma; neoplastic extramedullary hematopoiesis; tyrosine kinase inhibitor.

Publication types

  • Letter

MeSH terms

  • Biomarkers, Tumor
  • Bone Marrow / pathology*
  • Fusion Proteins, bcr-abl / genetics
  • Hematopoiesis, Extramedullary*
  • Humans
  • Leukemia, Myeloid, Chronic-Phase / diagnosis*
  • Leukemia, Myeloid, Chronic-Phase / drug therapy
  • Leukemia, Myeloid, Chronic-Phase / genetics
  • Molecular Targeted Therapy / methods
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects
  • Protein Kinase Inhibitors / therapeutic use
  • Sarcoma, Myeloid / diagnosis*
  • Sarcoma, Myeloid / genetics

Substances

  • Biomarkers, Tumor
  • Protein Kinase Inhibitors
  • Fusion Proteins, bcr-abl